Hwang Sena, Shin Dong Yeob, Kim Eun Kyung, Yang Woo Ick, Byun Jung Woo, Lee Su Jin, Kim Gyuri, Im Soo Jung, Lee Eun Jig
Division of Endocrinology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Department of Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Korea.
Yonsei Med J. 2015 Sep;56(5):1338-44. doi: 10.3349/ymj.2015.56.5.1338.
It is often difficult to discriminate focal lymphocytic thyroiditis (FLT) or adenomatous hyperplasia (AH) from thyroid cancer if they both have suspicious ultrasound (US) findings. We aimed to make a predictive model of FLT from papillary thyroid cancer (PTC) in suspicious nodules with benign cytologic results.
We evaluated 214 patients who had undergone fine-needle aspiration biopsy (FNAB) and had shown thyroid nodules with suspicious US features. PTC was confirmed by surgical pathology. FLT and AH were confirmed through more than two separate FNABs. Clinical and biochemical findings, as well as US features, were evaluated.
Of 214 patients, 100 patients were diagnosed with PTC, 55 patients with FLT, and 59 patients with AH. The proportion of elevated thyrotropin (TSH) levels (p=0.014) and thyroglobulin antibody (Tg-Ab) or thyroid peroxidase antibody (TPO-Ab) positivity (p<0.001) in the FLT group was significantly higher than that in the PTC group. Regarding US features, absence of calcification (p=0.006) and "diffuse thyroid disease" (DTD) pattern on US (p<0.001) were frequently seen in the FLT group. On multivariate analysis, Tg-Ab positivity, presence of a DTD pattern on US, and absence of calcification in nodules were associated with FLT with the best specificity of 99% and positive predictive value of 96%. In contrast, a taller than wide shape of nodules was the only variable significant for differentiating AH from PTC.
Suspicious thyroid nodules with cytologic benign results could be followed up with US rather than repeat FNAB, if patients exhibit Tg-Ab positivity, no calcifications in nodules, and a DTD pattern on US.
如果局灶性淋巴细胞性甲状腺炎(FLT)或腺瘤样增生(AH)均具有可疑的超声(US)表现,则通常很难将它们与甲状腺癌区分开来。我们旨在建立一个在具有良性细胞学结果的可疑结节中区分FLT与甲状腺乳头状癌(PTC)的预测模型。
我们评估了214例接受细针穿刺活检(FNAB)且甲状腺结节具有可疑US特征的患者。PTC通过手术病理确诊。FLT和AH通过两次以上单独的FNAB确诊。评估临床和生化检查结果以及US特征。
在214例患者中,100例被诊断为PTC,55例为FLT,59例为AH。FLT组促甲状腺激素(TSH)水平升高(p = 0.014)以及甲状腺球蛋白抗体(Tg-Ab)或甲状腺过氧化物酶抗体(TPO-Ab)阳性(p <0.001)的比例显著高于PTC组。关于US特征,FLT组中无钙化(p = 0.006)和US上的“弥漫性甲状腺疾病”(DTD)模式(p <0.001)较为常见。多因素分析显示,Tg-Ab阳性、US上存在DTD模式以及结节中无钙化与FLT相关,特异性最佳为99%,阳性预测值为96%。相比之下,结节纵横比大于1是区分AH与PTC的唯一显著变量。
如果患者表现出Tg-Ab阳性、结节无钙化且US上有DTD模式,则对于细胞学结果为良性的可疑甲状腺结节,可通过US进行随访,而非重复FNAB。